New York, NY
Assets: $2b
Revenue: $69m
MISSION:
LICR FUND, INC. IS A SUPPORTING ORGANIZATION OF THE LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.
Menands, NY
Assets: $901m
Revenue: $1b
Employees: 3k
MISSION:
The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of cancer.
New York, NY
Assets: $398m
Revenue: $362m
Employees: 288
MISSION:
THE FOUNDATION IS DEDICATED TO FINDING A CURE FOR PARKINSON'S DISEASE.
New York, NY
Assets: $274m
Revenue: $15m
MISSION:
PROVIDES THE ORGANIZATIONAL & FINANCIAL RESOURCES NECESSARY TO SUPPORT EYE RESEARCH
Westbury, NY
Assets: $211m
Revenue: $137m
Employees: 723
MISSION:
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH STRIVES TO IMPROVE THE HEALTH OF THE COMMUNITIES IT SERVES AND IS COMMITTED TO FINDING NEW ADVANCES IN MEDICINE THROUGH RESEARCH
New York, NY
Assets: $197m
Revenue: $60m
Employees: 55
MISSION:
TO ACCELERATE THE DISCOVERY & DEVELOPMENT OF NEW DRUGS TO FACILITATE THE CONTROL OF TUBERCULOSIS THROUGHOUT THE WORLD AND THE ACCESSIBILITY OF THESE DRUGS TO THE GLOBAL COMMUNITY.
New York, NY
Assets: $138m
Revenue: $32m
Employees: 32
MISSION:
SEE ON SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BYFUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FORALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY,TRANSLATIONAL, AND CLINICAL RESEARCH.
New York, NY
Assets: $136m
Revenue: $283m
Employees: 747
MISSION:
PHS' MISSION IS TO SUPPORT UNDERSERVED NEW YORK CITY FAMILIES IN ACHIEVING OPTIMAL HEALTH AND BUILDING PATHWAYS TO REACH THEIR POTENTIAL. AS THE LARGEST PUBLIC HEALTH NONPROFIT SERVING NEW YORK CITY, WE IMPROVE HEALTH OUTCOMES AND HELP COMMUNITIES THRIVE BY PROVIDING SERVICES DIRECTLY TO UNDERSERVED FAMILIES, SUPPORTING 200 COMMUNITY-BASED ORGANIZATIONS THROUGH OUR LONG-STANDING PUBLIC-PRIVATE PARTNERSHIPS AND BRIDGING THE GAP BETWEEN HEALTH CARE AND SOCIAL SERVICE ORGANIZATIONS THROUGH A COMMUNITY RESOURCE NETWORK. WE FOCUS ON A WIDE RANGE OF PUBLIC HEALTH ISSUES THAT OVERWHELMINGLY AFFECT THE ABILITY OF UNDERSERVED NEW YORKERS TO LIVE THEIR HEALTHIEST LIFE. THESE ISSUES INCLUDE FOOD AND NUTRITION, HEALTH INSURANCE, MATERNAL AND CHILD HEALTH, REPRODUCTIVE AND SEXUAL HEALTH, TOBACCO CONTROL, AND HIV/AIDS. PHS HAS A STRONG FOCUS ON HEALTH EQUITY TO ENSURE FAMILIES IN NEW YORK CITY HAVE THE BASICS FOR A HEALTHIER LIFE.
New York, NY
Assets: $112m
Revenue: $51m
Employees: 73
MISSION:
The goal of this organization is to support and fund-raise for a single institution within the Medical Research major group area.
New York, NY
Assets: $76m
Revenue: $61m
Employees: 217
MISSION:
CARDIOVASCULAR RESEARCH FOUNDATION IS AN INDEPENDENT, ACADEMICALLY FOCUSED ORGANIZATION DEDICATED TO IMPROVING THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH RESEARCH AND EDUCATION. THE ORGANIZATION HAS PLAYED A MAJOR ROLE IN REALIZING DRAMATIC IMPROVEMENTS IN THE LIVES OF COUNTLESS NUMBERS OF PATIENTS BY ESTABLISHING THE SAFE USE OF NEW TECHNOLOGIES AND THERAPIES IN THE SUBSPECIALTY OF INTERVENTIONAL CARDIOLOGY AND ENDOVASCULAR MEDICINE.
New York, NY
Assets: $69m
Revenue: $38m
Employees: 164
MISSION:
SEE SCHEDULE O.TO ADVANCE THE MOST CUTTING-EDGE STEM CELL RESEARCH IN THE WORLD, TO SUPPORT STEM CELL SCIENTISTS, AND TO EDUCATE THE PUBLIC.
New York, NY
Assets: $60m
Revenue: $7m
Employees: 9
MISSION:
THE FOUNDATION FUNDS RESEARCH TO FIND THE ROOT CAUSES OF AND NEW AND BETTER TREATMENTS FOR DEPRESSION, AS WELL AS PROGRAMS TO RAISE PUBLIC AWARENESS ABOUT THE ILLNESS.
New York, NY
Assets: $51m
Revenue: $29m
Employees: 79
MISSION:
AFMAR IS DEDICATED TO ENDING THE GLOBAL AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH. (SEE SCHEDULE O)
New York, NY
Assets: $47m
Revenue: $48m
Employees: 187
MISSION:
MAKE LIFE BETTER FOR PEOPLE WITH PARKINSON'S DISEASE BY IMPROVING CARE AND ADVANCING RESEARCH TOWARD A CURE.
Utica, NY
Assets: $44m
Revenue: $8m
Employees: 93
MISSION:
The goal of this organization is to conduct research which can be used to improve the options available to physicians who have advanced training in the development, implantation and utilization of cardiac pacemakers, cochlear implants and other hearing aids, artificial limbs and joints and other similar devices.
New York, NY
Assets: $39m
Revenue: $9m
Employees: 10
MISSION:
THE FOUNDATION IS DEDICATED TO THE EARLY DIAGNOSIS, TREATMENT AND ULTIMATE CURE OF PRIMARY IMMUNODEFICIENCY DISEASES. THE FOUNDATIONS PRIMARY MISSION IS SUPPORTING BASIC AND CLINICAL RESEARCH, PHYSICIAN EDUCATION, PATIENT SUPPORT, PUBLIC AWARENESS, ADVOCACY AND NEWBORN SCREENING. THE FOUNDATION GENERATES SUPPORT THROUGH CONTRIBUTIONS FROM THE GENERAL PUBLIC, INDUSTRY, AND GOVERNMENT AGENCIES. THE FOUNDATION SPONSORS PHYSICIAN SYMPOSIA, CONFERENCES, EDUCATIONAL EVENTS FOR PHYSICIANS AND PATIENTS, AND AWARENESS PROGRAMS TO REACH THE PUBLIC.
New York, NY
Assets: $38m
Revenue: $18m
Employees: 117
MISSION:
THE NATIONAL BLEEDING DISORDERS FOUNDATION (FORMERLY THE NATIONAL HEMOPHILIA FOUNDATION) IS DEDICATED TO FINDING CURES FOR INHERITABLE BLOOD AND BLEEDING DISORDERS AND TO ADDRESSING AND PREVENTING THE COMPLICATIONS OF THESE DISORDERS THROUGH RESEARCH, EDUCATION, AND ADVOCACY ENABLING PEOPLE AND FAMILIES TO THRIVE.
New York, NY
Assets: $34m
Revenue: $11m
Employees: 40
MISSION:
THE PURPOSE OF TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NY, INC. IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD FINDING THE CAUSE AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS.
New York, NY
Assets: $32m
Revenue: $17m
Employees: 48
MISSION:
THE CHILDREN'S TUMOR FOUNDATION IS DEDICATED TO ENDING NEUROFIBROMATOSIS (NF). OUR MISSION IS TO: A.) FUND RESEARCH, B.) INCREASE PUBLIC AWARENESS, C.) SUPPORT PATIENTS AND FAMILIES, D.) ENCOURAGE ESTABLISHMENT OF NF CLINICS.
New York, NY
Assets: $30m
Revenue: $7m
Employees: 7
MISSION:
TO FUND RESEARCH INTO THE CAUSE, CARE, AND CURE OF ALZHEIMER'S DISEASE AT THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE AT THE ROCKEFELLER UNIVERSITY IN NEW YORK THAT WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS.